Acquisition by Werner Robert F of 5633 shares of Twist Bioscience subject to Rule 16b-3
| TWST Stock | USD 45.12 0.50 1.10% |
Slightly above 62% of Twist Bioscience's investor base is looking to short. The analysis of the overall investor sentiment regarding Twist Bioscience Corp suggests that many traders are alarmed. Twist Bioscience's investing sentiment can be driven by a variety of factors including economic data, Twist Bioscience's earnings reports, geopolitical events, and overall market trends.
Twist |
Filed transaction by Twist Bioscience Corp officer. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Read at macroaxis.com
Twist Bioscience Fundamental Analysis
We analyze Twist Bioscience's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Twist Bioscience using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Twist Bioscience based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Earnings To Growth
Price To Earnings To Growth Comparative Analysis
Twist Bioscience is currently under evaluation in price to earnings to growth category among its peers. PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Twist Bioscience Corp Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Twist Bioscience stock to make a market-neutral strategy. Peer analysis of Twist Bioscience could also be used in its relative valuation, which is a method of valuing Twist Bioscience by comparing valuation metrics with similar companies.
Peers
Twist Bioscience Related Equities
| CDNA | Caredx | 5.63 | ||||
| NTRA | Natera | 3.64 | ||||
| CSTL | Castle Biosciences | 1.71 | ||||
| GH | Guardant Health | 1.22 | ||||
| IQV | IQVIA Holdings | 0.82 | ||||
| ILMN | Illumina | 0.43 | ||||
| TMO | Thermo Fisher | 0.13 | ||||
| A | Agilent Technologies | 0.30 | ||||
| DHR | Danaher | 0.42 | ||||
| MTD | Mettler Toledo | 0.68 | ||||
| EXAS | EXACT Sciences | 0.74 | ||||
| WAT | Waters | 0.75 | ||||
| ICLR | ICON PLC | 1.46 | ||||
| PSNL | Personalis | 6.35 |
Additional Tools for Twist Stock Analysis
When running Twist Bioscience's price analysis, check to measure Twist Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Twist Bioscience is operating at the current time. Most of Twist Bioscience's value examination focuses on studying past and present price action to predict the probability of Twist Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Twist Bioscience's price. Additionally, you may evaluate how the addition of Twist Bioscience to your portfolios can decrease your overall portfolio volatility.